Efficacy of Rifaximin, a Nonabsorbed Oral Antibiotic, in the Treatment of Small Intestinal Bacterial Overgrowth Marek Majewski, MD The American Journal of the Medical Sciences Volume 333, Issue 5, Pages 266-270 (May 2007) DOI: 10.1097/MAJ.0b013e3180536784 Copyright © 2007 Southern Society for Clinical Investigation Terms and Conditions
Figure 1 Figure demonstrating a statistically significant (P < 0.05) reduction in the concentration of hydrogen and methane gases expressed as area under the curve (AUC) on the Y-axis at baseline and after treatment with Rifaximin. (Data expressed as parts per million and actual numbers are shown in Table 3). The American Journal of the Medical Sciences 2007 333, 266-270DOI: (10.1097/MAJ.0b013e3180536784) Copyright © 2007 Southern Society for Clinical Investigation Terms and Conditions